Brief: Immutep Receives Approval To Initiate Insight-005 Trial Evaluating Eftilagimod Alpha And Anti-Pd-L1 Therapy Bavencio
01/05/2023 13:14
May 1 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP RECEIVES APPROVAL TO INITIATE INSIGHT-005 TRIAL
EVALUATING EFTILAGIMOD ALPHA AND ANTI-PD-L1 THERAPY BAVENCIO®
Source text for Eikon: ID:nGNX3MlSKn
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))